CME

Project ECHO® Learning Series

Join ACCC, Physicians’ Education Resource (PER), and Pharmacy Times Continuing Education (PTCE) for a series of expert-led telementoring sessions focused on the optimal use of bispecific antibodies as cancer immunotherapies.
Powered by OncoLens.

LEARN MORE

Hitting the Benchmarks in mCRC: A Precision Medicine Quality Initiative for the Care Team

0.75 CME/MOC/CC/NCPD/CPE/AAPA/IPCE

Topics — PeerView

Melanoma Oncolytic Immunotherapy: An Evolving Therapeutic Landscape

Maximum of 1.25 AMA PRA Category 1 Credit(s)™.

Topics — advanced melanoma, melanoma immunotherapy, oncolytic immunotherapy, PD-1 resistant melanoma, Vindico

Project ECHO® Learning Series: Evolving Role of Bispecific Antibodies as Cancer Therapy

These activities will be CME/CPE/CNE-certified.

Topics — ACCC, PER, Project ECHO, PTCE

Project ECHO®: Pulmonary Toxicities with Immune Checkpoint Inhibitors

Content Derived from a CME Certified Webinar in May 2023

Topics — ACCC, Boston University, immunotherapy, irAE, Project ECHO, pulmonology

Project ECHO®: Dermatologic Toxicities with Immune Checkpoint Inhibitors

Content Derived from a CME Certified Webinar in April 2023

Topics — ACCC, Boston University, dermatology, immunotherapy, irAE, Project ECHO

3-Part Aplastic Anemia On-Demand CME Education Series

This activity has been planned and implemented in accordance with the Essential Areas and policies of the Medical Society of Virginia through the joint providership with Carilion Clinic’s CME Program and OncoLens. Carilion Clinic’s CME Program is accredited by The Medical Society of Virginia to provide continuing medical education for physicians. Carilion Clinic’s CME Program designates this enduring material activity for a maximum of 3 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Topics — Carillion Clinic